(Q43970342)

28 November 2017

title

Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development (English)

1 reference

28 November 2017

Kurosawa S

1

1 reference

28 November 2017

Matsuzaki G

2

1 reference

28 November 2017

Harada M

3

1 reference

28 November 2017

Ando T

4

1 reference

28 November 2017

Nomoto K

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 1993

1 reference

European Journal of Immunology

28 November 2017

published in

1 reference

28 November 2017

volume

23

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

1029-1033

1 reference

Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Biology of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Cell-Mediated Immunity to Tumor Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Heterogeneity of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Role of NK cells in the control of metastatic spread and growth of tumor cells in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Role of nk cells in the antimetastatic effect of anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Role of NK cells in tumour growth and metastasis in beige mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Recombinant IL-2-activated NK cells mediate LAK activity against ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

The role of cytostasis in antitumor immunity: comparison between syngeneic and allogeneic systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Interferon: a cytotoxic T lymphocyte differentiation signal

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230507

7 January 2021

Identifiers

DOI

10.1002/EJI.1830230507

1 reference

28 November 2017

1 reference